Blockchain Registration Transaction Record

CNS Pharmaceuticals (NASDAQ: CNSP) Raises $5 Million in Public Offering

CNS Pharmaceuticals (NASDAQ: CNSP) raises $5 million through a public offering with a healthcare-focused investor. Proceeds will support the development of anti-cancer drugs, including Berubicin for brain and CNS cancers. A.G.P./Alliance Global Partners is the placement agent for the offering.

CNS Pharmaceuticals (NASDAQ: CNSP) Raises $5 Million in Public Offering

This news matters as it showcases CNS Pharmaceuticals' ability to secure funding for its pipeline of anti-cancer drug candidates, particularly Berubicin for brain and CNS cancers. The successful offering highlights investor confidence in the company's potential for developing innovative treatments in the oncology space.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x1b63abe98d14594a1e6990bbb341b45dac785cdd422b869e9677e1c1ed1cb97c
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintfast4izp-c8a0475ae3b6209a96fe633c38e60501